MicroRNA-mRNA interactions in a murine model of hyperoxia-induced bronchopulmonary dysplasia

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  Dong, Jie ^a,c   Carey, William A ^a   Abel, Stuart ^a,c   Collura, Christopher ^a,c   Jiang, Guoqian ^b   Tomaszek, Sandra ^a,c   Sutor, Shari ^a,c   Roden, Anja C ^a   Asmann, Yan W ^b   Prakash, Y S ^a,c   Wigle, Dennis A ^a,c  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA 29; OXYGEN; MEMBRANE PROTEIN; MICRORNA; MIRN29 MICRORNA, MOUSE; NTRK2 PROTEIN, MOUSE; PROTEIN TYROSINE KINASE;

AMBIENT AIR; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL CYCLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; GENE FUNCTION; GENE TARGETING; GENETIC REGULATION; HISTOPATHOLOGY; HYPEROXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG PARENCHYMA; MOLECULAR INTERACTION; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PREDICTION; RESPIRATORY TRACT INFLAMMATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STEM CELL; VALIDATION PROCESS; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; LUNG; LUNG INJURY; METABOLISM; PATHOLOGY;

MURINAE; MUS;

ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HYPEROXIA; LUNG; LUNG INJURY; MEMBRANE GLYCOPROTEINS; MICE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-TYROSINE KINASES; RNA, MESSENGER;

EID: 84861558186     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-204     Document Type: Article

References (48)

1. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967, 276:357-368. 10.1056/NEJM196702162760701, 5334613.
2. Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol 2006, 30:179-184. 10.1053/j.semperi.2006.05.004, 16860157.
3. Galambos C, Demello DE. Regulation of alveologenesis: clinical implications of impaired growth. Pathology 2008, 40:124-140. 10.1080/00313020701818981, 18203035.
4. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006, 367:1421-1431. 10.1016/S0140-6736(06)68615-7, 16650652.
5. Groenman F, Unger S, Post M. The molecular basis for abnormal human lung development. Biol Neonate 2005, 87:164-177. 10.1159/000082595, 15591817.
6. Coalson JJ. Experimental models of bronchopulmonary dysplasia. Biol Neonate 1997, 71(Suppl 1):35-38.
7. Dong J, Kislinger T, Jurisica I, Wigle DA. Lung cancer: developmental networks gone awry?. Cancer Biol Ther 2009, 8:312-318. 10.4161/cbt.8.4.7522, 2930783, 19202349.
8. Alejandre-Alcazar MA, Kwapiszewska G, Reiss I, Amarie OV, Marsh LM, Sevilla-Perez J, Wygrecka M, Eul B, Kobrich S, Hesse M, et al. Hyperoxia modulates TGFbeta/BMP signaling in a mouse model of bronchopulmonary dysplasia. Am J Physiol 2007, 292:L537-549.
9. Warner BB, Stuart LA, Papes RA, Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998, 275:L110-117.
10. Maeda Y, Dave V, Whitsett JA. Transcriptional control of lung morphogenesis. Physiol Rev 2007, 87:219-244. 10.1152/physrev.00028.2006, 17237346.
11. Dong J, Jiang G, Asmann YW, Tomaszek S, Jen J, Kislinger T, Wigle DA. MicroRNA networks in mouse lung organogenesis. PLoS One 2010, 5:e10854. 10.1371/journal.pone.0010854, 2877109, 20520778.
12. Du T, Zamore PD. microPrimer: the biogenesis and function of microRNA. Development 2005, 132:4645-4652. 10.1242/dev.02070, 16224044.
13. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006, 38:228-233. 10.1038/ng1725, 2538576, 16380711.
14. Rajewsky N. microRNA target predictions in animals. Nat Genet 2006, 38(Suppl):S8-13.
15. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773. 10.1038/nature03315, 15685193.
16. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development 2005, 132:4653-4662. 10.1242/dev.02073, 16224045.
17. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838. 10.1038/nature03702, 15944708.
18. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005, 122:6-7. 10.1016/j.cell.2005.06.036, 16009126.
19. Gauldie J, Galt T, Bonniaud P, Robbins C, Kelly M, Warburton D. Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol 2003, 163:2575-2584. 10.1016/S0002-9440(10)63612-7, 3278797, 14633629.
20. Sinkin RA, Roberts M, LoMonaco MB, Sanders RJ, Metlay LA. Fibronectin expression in bronchopulmonary dysplasia. Pediatr Dev Pathol 1998, 1:494-502. 10.1007/s100249900068, 9724336.
21. Asikainen TM, Waleh NS, Schneider BK, Clyman RI, White CW. Enhancement of angiogenic effectors through hypoxia-inducible factor in preterm primate lung in vivo. Am J Physiol 2006, 291:L588-595.
22. Capoluongo E, Ameglio F, Zuppi C. Insulin-like growth factor-I and complications of prematurity: a focus on bronchopulmonary dysplasia. Clin Chem Lab Med 2008, 46:1061-1066.
23. McGrath-Morrow SA, Cho C, Soutiere S, Mitzner W, Tuder R. The effect of neonatal hyperoxia on the lung of p21Waf1/Cip1/Sdi1-deficient mice. Am J Respir Cell Mol Biol 2004, 30:635-640. 10.1165/rcmb.2003-0049OC, 14607813.
24. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36:D154-158. 10.1093/nar/gkn221, 2238936, 17991681.
25. Huang JC, Babak T, Corson TW, Chua G, Khan S, Gallie BL, Hughes TR, Blencowe BJ, Frey BJ, Morris QD. Using expression profiling data to identify human microRNA targets. Nat Methods 2007, 4:1045-1049. 10.1038/nmeth1130, 18026111.
26. Wang YP, Li KB. Correlation of expression profiles between microRNAs and mRNA targets using NCI-60 data. BMC Genomics 2009, 10:218. 10.1186/1471-2164-10-218, 2686738, 19435500.
27. Jayaswal V, Lutherborrow M, Ma DD, Hwa Yang Y. Identification of microRNAs with regulatory potential using a matched microRNA-mRNA time-course data. Nucleic Acids Res 2009, 37:e60. 10.1093/nar/gkp153, 2677888, 19295134.
28. Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Thannickal VJ, Cardoso WV, Lu J. MIR-29 is a Major Regulator of Genes Associated with Pulmonary Fibrosis. Am J Respir Cell Mol Biol 2011, 45:287-294. 10.1165/rcmb.2010-0323OC, 3175558, 20971881.
29. Pandit KV, Milosevic J, Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 2011, 157:191-199. 10.1016/j.trsl.2011.01.012, 21420029.
30. Garcia-Suarez O, Perez-Pinera P, Laura R, Germana A, Esteban I, Cabo R, Silos-Santiago I, Cobo JL, Vega JA. TrkB is necessary for the normal development of the lung. Respir Physiol Neurobiol 2009, 167:281-291. 10.1016/j.resp.2009.06.001, 19523540.
31. Dong J, Sutor S, Jiang G, Cao Y, Asmann YW, Wigle DA. c-Myc regulates self- renewal in bronchoalveolar stem cells. PLoS One 2011, 6:e23707. 10.1371/journal.pone.0023707, 3157444, 21858211.
32. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT, Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005, 121:823-835. 10.1016/j.cell.2005.03.032, 15960971.
33. Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, Desano JT, Bommer GT, Fan D, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 2009, 4:e6816. 10.1371/journal.pone.0006816, 2729376, 19714243.
34. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233. 10.1016/j.cell.2009.01.002, 19167326.
35. Gaidatzis D, van Nimwegen E, Hausser J, Zavolan M. Inference of miRNA targets using evolutionary conservation and pathway analysis. BMC Bioinforma 2007, 8:69.
36. Ambalavanan N, Carlo WA, D'Angio CT, McDonald SA, Das A, Schendel D, Thorsen P, Higgins RD. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009, 123:1132-1141. 10.1542/peds.2008-0526, 2903210, 19336372.
37. Das KC, Ravi D, Holland W. Increased apoptosis and expression of p21 and p53 in premature infant baboon model of bronchopulmonary dysplasia. Antioxid Redox Signal 2004, 6:109-116. 10.1089/152308604771978417, 14713342.
38. O'Reilly MA, Staversky RJ, Watkins RH, Reed CK, de Mesy Jensen KL, Finkelstein JN, Keng PC. The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am J Respir Cell Mol Biol 2001, 24:703-710.
39. Vicencio AG, Lee CG, Cho SJ, Eickelberg O, Chuu Y, Haddad GG, Elias JA. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia?. Am J Respir Cell Mol Biol 2004, 31:650-656. 10.1165/rcmb.2004-0092OC, 15333328.
40. Thebaud B, Abman SH. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 2007, 175:978-985. 10.1164/rccm.200611-1660PP, 2176086, 17272782.
41. DeLisser HM, Helmke BP, Cao G, Egan PM, Taichman D, Fehrenbach M, Zaman A, Cui Z, Mohan GS, Baldwin HS, et al. Loss of PECAM-1 function impairs alveolarization. J Biol Chem 2006, 281:8724-8731. 10.1074/jbc.M511798200, 16377626.
42. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt- 1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001, 164:1971-1980.
43. Dasgupta C, Sakurai R, Wang Y, Guo P, Ambalavanan N, Torday JS, Rehan VK. Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol 2009, 296:L1031-1041.
44. Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC genomics 2007, 8:166. 10.1186/1471-2164-8-166, 1904203, 17565689.
45. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33:e179. 10.1093/nar/gni178, 1292995, 16314309.
46. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264. 10.1093/biostatistics/4.2.249, 12925520.
47. Reimand J, Kull M, Peterson H, Hansen J, Vilo J. g:Profiler-a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res 2007, 35:W193-200. 10.1093/nar/gkm226, 1933153, 17478515.
48. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.